The Valley Desk

NCT02462811 · Interventional trial

A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)

Overall registry status Completed

Phase 3

Conditions Nausea, Pain, Vomiting

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov